KR102550113B1 - 전립선암 진단용 바이오마커 및 이의 용도 - Google Patents

전립선암 진단용 바이오마커 및 이의 용도 Download PDF

Info

Publication number
KR102550113B1
KR102550113B1 KR1020210069428A KR20210069428A KR102550113B1 KR 102550113 B1 KR102550113 B1 KR 102550113B1 KR 1020210069428 A KR1020210069428 A KR 1020210069428A KR 20210069428 A KR20210069428 A KR 20210069428A KR 102550113 B1 KR102550113 B1 KR 102550113B1
Authority
KR
South Korea
Prior art keywords
hsa
mir
prostate cancer
mirna
lncrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020210069428A
Other languages
English (en)
Korean (ko)
Other versions
KR20220161039A (ko
Inventor
최관용
김종민
허태양
Original Assignee
주식회사 시스바이오젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020210069428A priority Critical patent/KR102550113B1/ko
Application filed by 주식회사 시스바이오젠 filed Critical 주식회사 시스바이오젠
Priority to JP2023573568A priority patent/JP2024521869A/ja
Priority to US18/565,020 priority patent/US20250283176A1/en
Priority to PCT/KR2022/007695 priority patent/WO2022250517A1/ko
Priority to EP22811708.1A priority patent/EP4365310A4/en
Publication of KR20220161039A publication Critical patent/KR20220161039A/ko
Priority to KR1020230082463A priority patent/KR20230106542A/ko
Application granted granted Critical
Publication of KR102550113B1 publication Critical patent/KR102550113B1/ko
Assigned to 포항공과대학교 산학협력단 reassignment 포항공과대학교 산학협력단 권리의 일부이전등록 Assignors: 주식회사 시스바이오젠
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020210069428A 2021-05-28 2021-05-28 전립선암 진단용 바이오마커 및 이의 용도 Active KR102550113B1 (ko)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020210069428A KR102550113B1 (ko) 2021-05-28 2021-05-28 전립선암 진단용 바이오마커 및 이의 용도
US18/565,020 US20250283176A1 (en) 2021-05-28 2022-05-30 Biomarker for diagnosing prostate cancer and use thereof
PCT/KR2022/007695 WO2022250517A1 (ko) 2021-05-28 2022-05-30 전립선암 진단용 바이오마커 및 이의 용도
EP22811708.1A EP4365310A4 (en) 2021-05-28 2022-05-30 Biomarkers for the diagnosis of prostate cancer and their use
JP2023573568A JP2024521869A (ja) 2021-05-28 2022-05-30 前立腺癌診断用バイオマーカー及びその使用
KR1020230082463A KR20230106542A (ko) 2021-05-28 2023-06-27 전립선암 진단용 바이오마커 및 이의 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210069428A KR102550113B1 (ko) 2021-05-28 2021-05-28 전립선암 진단용 바이오마커 및 이의 용도

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020230082463A Division KR20230106542A (ko) 2021-05-28 2023-06-27 전립선암 진단용 바이오마커 및 이의 용도

Publications (2)

Publication Number Publication Date
KR20220161039A KR20220161039A (ko) 2022-12-06
KR102550113B1 true KR102550113B1 (ko) 2023-07-03

Family

ID=84229115

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020210069428A Active KR102550113B1 (ko) 2021-05-28 2021-05-28 전립선암 진단용 바이오마커 및 이의 용도
KR1020230082463A Withdrawn KR20230106542A (ko) 2021-05-28 2023-06-27 전립선암 진단용 바이오마커 및 이의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020230082463A Withdrawn KR20230106542A (ko) 2021-05-28 2023-06-27 전립선암 진단용 바이오마커 및 이의 용도

Country Status (5)

Country Link
US (1) US20250283176A1 (https=)
EP (1) EP4365310A4 (https=)
JP (1) JP2024521869A (https=)
KR (2) KR102550113B1 (https=)
WO (1) WO2022250517A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013526852A (ja) * 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
US10801072B2 (en) * 2014-09-04 2020-10-13 Miodx Method of analysis allowing avoidance of surgery
ES2749651T3 (es) * 2015-02-11 2020-03-23 Region Midtjylland Método basado en microARN para la detección temprana de cáncer de próstata en muestras de orina
KR102414106B1 (ko) * 2020-03-12 2022-06-29 (주) 바이오인프라생명과학 유방암 진단용 다중 바이오마커 및 이의 용도

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Clin Cancer Res, 25(10): 3016-3025 (2019.02.26.)*
Clin Chim Acta, 473: 96-105 (2017.08.12.)*
Eur Urol Focus, 4(6): 825-833 (2017.03.09.)*

Also Published As

Publication number Publication date
EP4365310A4 (en) 2025-12-17
EP4365310A1 (en) 2024-05-08
KR20230106542A (ko) 2023-07-13
WO2022250517A1 (ko) 2022-12-01
US20250283176A1 (en) 2025-09-11
JP2024521869A (ja) 2024-06-04
KR20220161039A (ko) 2022-12-06

Similar Documents

Publication Publication Date Title
US20230366034A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
EP2138848A1 (en) Method for the diagnosis and/or prognosis of cancer of the bladder
CN102947468B (zh) 大肠肿瘤的检测方法
CN109504780B (zh) 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法
CN101855348A (zh) 肝癌相关基因、以及肝癌风险的判定方法
CN109371133B (zh) 一组与胰腺癌相关的LncRNA分子标记物及其应用
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
CN111424085B (zh) tRNA来源片段在制备乳腺癌诊断试剂中的应用
CN114916233A (zh) 泛癌症早筛预测方法
CN114836538B (zh) 生物标志物在hbv相关肝癌诊断及预后中的应用
CN111808966B (zh) miRNA在诊断乳腺癌患病风险的应用
KR102550113B1 (ko) 전립선암 진단용 바이오마커 및 이의 용도
US7217515B2 (en) HURP gene as a molecular marker for bladder cancer
KR102052398B1 (ko) 전립선암 진단용 바이오마커 및 이의 용도
US11542559B2 (en) Methylation-based biomarkers in breast cancer screening, diagnosis, or prognosis
CN118995931A (zh) LncRNA AC113143.1作为结肠癌诊断标志物的应用
CN113444805B (zh) 检测组织中tRF表达引物在制备喉癌辅助诊断试剂盒的应用
CN112391478B (zh) 外泌体mRNA在乳腺疾病诊断中的应用
CN118922561A (zh) 肾癌诊断用尿液miRNA标志物、诊断试剂及试剂盒
CN110343761B (zh) 前列腺癌的标志物组及其应用
CN114410795A (zh) 基于miRNA特征标记的肝癌早期检测
US11676724B1 (en) Method of calculating diagnostic score for prostate cancer and use thereof
KR20220151482A (ko) 전립선암 진단용 바이오마커
EP4212632A1 (en) Method for calculating prostate cancer diagnostic score, and uses thereof
CN107723366B (zh) 一种与贲门癌辅助诊断相关的血清miRNA标志物及其应用

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20210528

PA0201 Request for examination
PA0302 Request for accelerated examination

Patent event date: 20210528

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210927

Patent event code: PE09021S01D

AMND Amendment
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220218

Patent event code: PE09021S01D

PE0601 Decision on rejection of patent

Patent event date: 20220628

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220218

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20210927

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220628

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20211126

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221125

Patent event code: PE09021S01D

PG1501 Laying open of application
AMND Amendment
PX0701 Decision of registration after re-examination

Patent event date: 20230420

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20221209

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20221028

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20220628

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20211126

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230627

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230628

End annual number: 3

Start annual number: 1

PG1601 Publication of registration